Amplifikasi CCNE1, Ekspresi mRNA CCNE1, dan Instabilitas Genom pada Karsinoma Serosa Ovarium: Analisis Terintegrasi TCGA PanCancer Atlas

CCNE1 amplification is a recurrent copy-number alteration in serous ovarian carcinoma and is thought to be associated with transcriptional activation and chromosomal instability. This study aimed to analyze the frequency of CCNE1 amplification, its association with mRNA expression, and differences in genomic instability characteristics according to amplification status. This retrospective analytical observational study used data from 201 primary tumors in the TCGA PanCancer Atlas accessed through cBioPortal. Amplification was defined as GISTIC +2. mRNA expression was analyzed as a continuous z-score, while a z-score >= 2 was used for exploratory categorical analysis. Tumor break load, aneuploidy score, fraction genome altered, mutation count, and nonsynonymous TMB were compared according to amplification status. CCNE1 amplification was identified in 43 of 201 tumors (21.4%). mRNA expression increased in accordance with the GISTIC category (Kruskal-Wallis, p < 0.001; Spearman rho = 0.607), and the amplified group showed higher expression z-scores than the non-amplified group (median 1.99 vs. 0.05; p < 0.001; rank-biserial correlation = 0.616). Amplification was also associated with high expression (OR = 7.92; 95% CI 3.62-17.30), although individual-level concordance was not perfect. Tumors with CCNE1 amplification had higher tumor break load and aneuploidy scores (both p < 0.001; q < 0.003), whereas fraction genome altered, mutation count, and TMB did not differ significantly. These findings indicate that CCNE1 amplification defines a subset of serous ovarian carcinomas characterized by increased mRNA expression and features of chromosomal instability. Integrating copy-number alteration and gene expression data may provide more informative molecular stratification than using either marker alone.

Authors

Institutions

Publication Details

Journal
Jurnal Medika Nusantara
Published
2026-11-13
DOI
https://doi.org/10.59680/medika.v4i4.1662
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Amplifikasi CCNE1, Ekspresi mRNA CCNE1, dan Instabilitas Genom pada Karsinoma Serosa Ovarium: Analisis Terintegrasi TCGA PanCancer Atlas

Chris Adhiyanto, Afiati Afiati, Auliyani Andam Suri, Dianidya Kumandang Sari et al.
2 links
Jurnal Medika Nusantara
Ovarian cancer diagnosis and treatment
article

Amplifikasi CCNE1, Ekspresi mRNA CCNE1, dan Instabilitas Genom pada Karsinoma Serosa Ovarium: Analisis Terintegrasi TCGA PanCancer Atlas

Chris Adhiyanto, Afiati Afiati, Auliyani Andam Suri, Dianidya Kumandang Sari, Devy Ariany, Irma Dewi
article en

Abstract

CCNE1 amplification is a recurrent copy-number alteration in serous ovarian carcinoma and is thought to be associated with transcriptional activation and chromosomal instability. This study aimed to analyze the frequency of CCNE1 amplification, its association with mRNA expression, and differences in genomic instability characteristics according to amplification status. This retrospective analytical observational study used data from 201 primary tumors in the TCGA PanCancer Atlas accessed through cBioPortal. Amplification was defined as GISTIC +2. mRNA expression was analyzed as a continuous z-score, while a z-score >= 2 was used for exploratory categorical analysis. Tumor break load, aneuploidy score, fraction genome altered, mutation count, and nonsynonymous TMB were compared according to amplification status. CCNE1 amplification was identified in 43 of 201 tumors (21.4%). mRNA expression increased in accordance with the GISTIC category (Kruskal-Wallis, p < 0.001; Spearman rho = 0.607), and the amplified group showed higher expression z-scores than the non-amplified group (median 1.99 vs. 0.05; p < 0.001; rank-biserial correlation = 0.616). Amplification was also associated with high expression (OR = 7.92; 95% CI 3.62-17.30), although individual-level concordance was not perfect. Tumors with CCNE1 amplification had higher tumor break load and aneuploidy scores (both p < 0.001; q < 0.003), whereas fraction genome altered, mutation count, and TMB did not differ significantly. These findings indicate that CCNE1 amplification defines a subset of serous ovarian carcinomas characterized by increased mRNA expression and features of chromosomal instability. Integrating copy-number alteration and gene expression data may provide more informative molecular stratification than using either marker alone.

Jurnal Medika NusantaraVol. 4(4)
Syarif Hidayatullah State Islamic University Jakarta (ID)
Good health and well-being
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon